View the full Surgery list with 48 results.

Matching Calls

• Прагматични клинични изпитвания за оптимизиране на имунотерапевтичните интервенции при пациенти с рефрактерен рак

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Фаза 1, включваща клинични изпитвания при хора за тестване на лекарства, ръководени от биомаркери, или мултимодални интервенции за лечение на пациенти с редки или много редки ракови заболявания или ракови подтипове

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fáze 1 zahrnující klinické studie prováděné první osobou za účelem testování léčivých přípravků řízených biomarkerem nebo multimodálních léčebných intervencí u pacientů se vzácnými nebo velmi vzácnými nádorovými onemocněními nebo podtypy nádorových onemocnění

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatické klinické studie k optimalizaci imunoterapeutických intervencí u pacientů s refrakterními nádory

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Pragmatiske kliniske forsøg til optimering af immunterapeutiske indgreb hos patienter med refraktær kræft

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fase 1, herunder første kliniske forsøg på mennesker med henblik på at teste biomarkørstyrede lægemidler eller multimodale behandlingsinterventioner for patienter med sjældne eller meget sjældne kræftformer eller kræftsubtyper

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatische klinische Studien zur Optimierung immuntherapeutischer Interventionen bei Patienten mit refraktärem Krebs

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Phase 1, einschließlich klinischer Studien zum ersten Mal am Menschen, um biomarkergeführte Arzneimittel oder multimodale Behandlungsinterventionen für Patienten mit seltenen oder sehr seltenen Krebsarten oder Krebssubtypen zu testen

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Πρακτικές κλινικές δοκιμές για τη βελτιστοποίηση των ανοσοθεραπευτικών παρεμβάσεων για ασθενείς με ανθεκτικούς καρκίνους

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Φάση 1, συμπεριλαμβανομένων των πρώτων στον άνθρωπο κλινικών δοκιμών για τη δοκιμή φαρμάκων καθοδηγούμενων από βιοδείκτες ή πολυτροπικών θεραπευτικών παρεμβάσεων για ασθενείς με σπάνιους ή πολύ σπάνιους καρκίνους ή υποτύπους καρκίνου

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Ensayos clínicos pragmáticos para optimizar las intervenciones inmunoterapéuticas en pacientes con cánceres refractarios

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fase 1, incluidos los primeros ensayos clínicos en humanos para probar medicamentos guiados por biomarcadores o intervenciones de tratamiento multimodal para pacientes con cánceres o subtipos de cáncer raros o muy raros

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmaatilised kliinilised uuringud immunoterapeutiliste sekkumiste optimeerimiseks refraktaarse vähiga patsientidel

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• etapp, mis hõlmab esimese inimese kliinilisi uuringuid, et katsetada biomarkeril põhinevaid ravimeid või multimodaalseid raviprotseduure harvaesinevate või väga harvaesinevate vähivormide või vähi alatüüpidega patsientidel

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Vaihe 1, mukaan lukien ensimmäiset kliiniset tutkimukset, joissa testataan biomerkkiaineohjattuja lääkkeitä tai multimodaalisia hoitotoimenpiteitä harvinaisia tai erittäin harvinaisia syöpiä tai syövän alatyyppejä sairastaville potilaille

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmaattiset kliiniset tutkimukset immunoterapeuttisten toimenpiteiden optimoimiseksi potilaille, joilla on refraktorisia syöpiä

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Phase 1 incluant les premiers essais cliniques sur l'homme pour tester des médicaments guidés par des biomarqueurs ou des interventions de traitement multimodal chez des patients atteints de cancers ou de sous-types de cancer rares ou très rares

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Essais cliniques pragmatiques pour optimiser les interventions immunothérapeutiques chez les patients atteints de cancers réfractaires

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Trialacha cliniciúla pragmatacha chun idirghabhálacha imdhíon-theiripeacha a bharrfheabhsú d’othair a bhfuil ailsí teasfhulangacha orthu

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Céim 1 lena n-áirítear trialacha cliniciúla duine le duine chun cógais faoi threoir bithmharcóra nó idirghabhálacha cóireála ilmhódacha a thástáil d’othair a bhfuil ailsí nó fochineálacha ailse neamhchoitianta nó an-annamh orthu

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatična klinička ispitivanja za optimizaciju imunoterapijskih intervencija u bolesnika s refraktornim rakom

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Faza 1., uključujući prva klinička ispitivanja na ljudima za ispitivanje lijekova na temelju biomarkera ili multimodalne intervencije liječenja za bolesnike s rijetkim ili vrlo rijetkim vrstama raka ili podtipovima raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• 1. szakasz, beleértve a biomarkerek által vezérelt gyógyszerek vagy multimodális kezelési beavatkozások tesztelésére irányuló első humán klinikai vizsgálatokat ritka vagy nagyon ritka daganatos betegségekben vagy daganatos altípusokban szenvedő betegeknél

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatikus klinikai vizsgálatok a refrakter daganatos betegek immunterápiás beavatkozásainak optimalizálására

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Studi clinici pragmatici per ottimizzare gli interventi immunoterapeutici per i pazienti con tumori refrattari

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fase 1, compresi i primi studi clinici sull'uomo per testare medicinali guidati da biomarcatori o interventi terapeutici multimodali per pazienti con tumori o sottotipi di cancro rari o molto rari

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatiški klinikiniai tyrimai, skirti imunoterapinėms intervencijoms optimizuoti pacientams, sergantiems atspariu vėžiu

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• 1 etapas, įskaitant pirmojo žmogaus klinikinius tyrimus, kuriais siekiama išbandyti biologiniais žymenimis grindžiamus vaistus arba daugiarūšio gydymo intervencines priemones pacientams, sergantiems retomis arba labai retomis vėžio formomis arba vėžio potipiais

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatiski klīniskie pētījumi imūnterapijas pasākumu optimizēšanai pacientiem ar refraktāru vēzi

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• fāze, kas ietver pirmos klīniskos izmēģinājumus ar cilvēkiem, lai pārbaudītu biomarķieru vadītas zāles vai multimodālas ārstēšanas intervences pacientiem ar retiem vai ļoti retiem vēža veidiem vai vēža apakštipiem

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Fażi 1 li tinkludi provi kliniċi tal-ewwel bniedem biex jiġu ttestjati mediċini ggwidati minn bijomarkatur jew interventi ta’ trattament multimodali għal pazjenti b’kanċers jew sottotipi ta’ kanċer rari jew rari ħafna

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Provi kliniċi prammatiċi biex jiġu ottimizzati l-interventi immunoterapewtiċi għal pazjenti b’kanċers refrattarji

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fase 1 met inbegrip van eerste klinische proeven bij de mens om biomarkergeleide geneesmiddelen of multimodale behandelingsinterventies te testen voor patiënten met zeldzame of zeer zeldzame vormen van kanker of subtypes van kanker

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatische klinische studies om immunotherapeutische interventies voor patiënten met refractaire kankers te optimaliseren

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Faza 1 obejmująca pierwsze badania kliniczne z udziałem ludzi w celu przetestowania leków kierowanych biomarkerami lub interwencji w leczeniu multimodalnym u pacjentów z rzadkimi lub bardzo rzadkimi nowotworami lub podtypami raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatyczne badania kliniczne mające na celu optymalizację interwencji immunoterapeutycznych u pacjentów z nowotworami opornymi na leczenie

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fase 1, incluindo ensaios clínicos em seres humanos para testar medicamentos guiados por biomarcadores ou intervenções de tratamento multimodal em doentes com cancros raros ou muito raros ou subtipos de cancro

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Ensaios clínicos pragmáticos para otimizar as intervenções imunoterapêuticas em doentes com cancros refratários

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Studii clinice pragmatice pentru optimizarea intervențiilor imunoterapeutice la pacienții cu cancer refractar

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Faza 1, inclusiv primele studii clinice la om pentru testarea medicamentelor ghidate de biomarkeri sau a intervențiilor de tratament multimodal pentru pacienții cu forme de cancer sau subtipuri de cancer rare sau foarte rare

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatické klinické štúdie na optimalizáciu imunoterapeutických intervencií u pacientov s refraktérnym karcinómom

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fáza 1 vrátane prvého klinického skúšania na ľuďoch zameraného na testovanie liekov riadených biomarkermi alebo multimodálnych liečebných zásahov u pacientov so zriedkavými alebo veľmi zriedkavými druhmi rakoviny alebo podtypmi rakoviny

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatična klinična preskušanja za optimizacijo imunoterapevtskih posegov pri bolnikih z neodzivnim rakom

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Faza 1, vključno s prvimi kliničnimi preskušanji na ljudeh za preskušanje zdravil, vodenih z biološkimi označevalci, ali večmodalnih ukrepov zdravljenja za bolnike z redkimi ali zelo redkimi vrstami raka ali podtipi raka

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU

• Pragmatiska kliniska prövningar för att optimera immunterapeutiska interventioner för patienter med refraktär cancer

  Deadline

  Sep 15, 2026

  Keywords

  HORIZON-MISS-2026-02-CANCER-03HORIZON-MISS-2026-02Anticancer therapyDiagnostic tools (e.g. genetic, imaging)HaematologyMedical devicesPaediatricsPharmacogenomicsPharmacology, pharmacogenomics, drug discovery and design, drug therapyRadiation therapyStem cell therapySurgery

  Type

  View on EU

• Fas 1 inklusive kliniska första-i-mänskliga prövningar för att testa biomarkörstyrda läkemedel eller multimodala behandlingsinterventioner för patienter med sällsynta eller mycket sällsynta cancerformer eller cancersubtyper

  Deadline

  Sep 21, 2027

  Keywords

  HORIZON-MISS-2027-02-CANCER-03HORIZON-MISS-2027-02Anticancer therapyBiophotonics, Imaging, image and data processingCancer and its biological basisQuality-of-lifeRadiation therapySurgeryTomography

  Type

  View on EU